NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Human Papillomavirus



Recent findings illuminate research in human papillomavirus



November 3rd, 2005

Investigators in the United States and Brazil have published new human papillomavirus data.

Study 1: Researchers compare the test performance of Inform HPV and hybrid capture 2 high-risk HPV DNA tests using the Surepath liquid-based Pap test as the collection method in a recent issue of the American Journal of Clinical Pathology.

"No U.S. Food and Drug Administration-approved method is available to test for human papillomavirus (HPV) DNA in the SurePath liquid-based Papanicolaou (Pap) test (TriPath Care Technologies, Burlington, NC). We compared the performance characteristics of Inform HPV (Ventana Medical Systems, Tucson, AZ) and Hybrid...


Source: Women's Health Weekly (2005-11-03)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login